|
51st Annual ASH Meeting The IMF brings you highlights from the 51st annual meeting of the American Society of Hematology. We interviewed over 50 of the myeloma experts at the meeting, covering over 80 of the presentations being made about myeloma.
These videos are now up on the web, along with the presentation abstracts and slides where available. If you have any issues with the videos not playing properly, please upgrade your Adobe Flash Player.This is free software provided by Adobe Systems.
|
|
|
|
|
"For the first time, we are seeing the role of the novel agents across the whole spectrum of myeloma"
View
|
|
|
|
|
|
Paul Richardson, MD
Dana Farber Cancer Institute
Boston, Massachusetts
View
|
|
|
|
|
|
Sundar Jagannath, MD
St. Vincents Comprehensive Cancer Center
New York, NY
View
|
|
|
|
|
|
"This has been the most exciting and promising American Society of Hematology meeting in the last ten years"
View
|
|
|
|
|
|
"There are many important presentations at this ASH meeting"
View
|
|
|
|
|
|
"Today we reported on three drugs that will be part of future treatment choices for myeloma patients."
View
|
|
|
|
back
print
back to top